Clinical and experimental studies indicate that the progression of renal disease is faster in males than females. These observations are corroborated by a sexual dimorphism observed in the polygenetic MWF (Munich Wistar Frömter) rat model. The age-dependent spontaneous progression of increased UAE (urinary albumin excretion) in male MWF rats is influenced by multiple QTLs (quantitative trait loci). In contrast, female MWF rats only develop a slight increase in UAE, while the role of genetic factors for this phenotype is unknown. In the present study, we show that, compared with resistant SHRs (spontaneously hypertensive rats), both male and female MWF rats develop a significant increase in UAE at 24 weeks of age (P<0.0001), although blood pressures were lower compared with SHRs (P<0.0001). UAE was significantly higher in male (7-fold) compared with female MWF rats (162.6±15.9 compared with 24.0±5.5 mg/24 h respectively; P<0.0001), and only male MWF rats developed significant glomerulosclerosis and tubulointerstitial damage in the kidney (P<0.0001). To test the role of genetic factors in the development of low grade albuminuria in female MWF rats, we analysed the role of a major UAE QTL on rat chromosome 6. To this end, we analysed a consomic MWF-6SHR strain in which chromosome 6 from SHRs was introgressed into the MWF rat background. Time course analysis of UAE in females indicated that the small increase in UAE in MWF rats was fully suppressed by exchange of rat chromosome 6. Thus, taken together with previous studies in males, we show that RNO6 protects against the increase in albuminuria with age in both female and male MWF rats.
Skip Nav Destination
Article navigation
February 2008
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Research Article|
January 15 2008
Protective effect of female gender on the development of albuminuria in a polygenetic rat model is enhanced further by replacement of a major autosomal QTL
Angela Schulz;
Angela Schulz
*Institut für Klinische Pharmakologie und Toxikologie, Charité Centrum für Thearapieforschung, Charité–Universitätsmedizin Berlin, Berlin, Germany
Search for other works by this author on:
Maria Schlesener;
Maria Schlesener
*Institut für Klinische Pharmakologie und Toxikologie, Charité Centrum für Thearapieforschung, Charité–Universitätsmedizin Berlin, Berlin, Germany
Search for other works by this author on:
Judith Weiss;
Judith Weiss
*Institut für Klinische Pharmakologie und Toxikologie, Charité Centrum für Thearapieforschung, Charité–Universitätsmedizin Berlin, Berlin, Germany
Search for other works by this author on:
Jonna Hänsch;
Jonna Hänsch
*Institut für Klinische Pharmakologie und Toxikologie, Charité Centrum für Thearapieforschung, Charité–Universitätsmedizin Berlin, Berlin, Germany
Search for other works by this author on:
Norbert Wendt;
Norbert Wendt
*Institut für Klinische Pharmakologie und Toxikologie, Charité Centrum für Thearapieforschung, Charité–Universitätsmedizin Berlin, Berlin, Germany
Search for other works by this author on:
Peter Kossmehl;
Peter Kossmehl
*Institut für Klinische Pharmakologie und Toxikologie, Charité Centrum für Thearapieforschung, Charité–Universitätsmedizin Berlin, Berlin, Germany
Search for other works by this author on:
Daniela Grimm;
Daniela Grimm
*Institut für Klinische Pharmakologie und Toxikologie, Charité Centrum für Thearapieforschung, Charité–Universitätsmedizin Berlin, Berlin, Germany
Search for other works by this author on:
Roland Vetter;
Roland Vetter
*Institut für Klinische Pharmakologie und Toxikologie, Charité Centrum für Thearapieforschung, Charité–Universitätsmedizin Berlin, Berlin, Germany
Search for other works by this author on:
Reinhold Kreutz
*Institut für Klinische Pharmakologie und Toxikologie, Charité Centrum für Thearapieforschung, Charité–Universitätsmedizin Berlin, Berlin, Germany
†Medizinische Poliklinik, Charité Centrum für Innere Medizin und Dermatologie, Charité–Universitätsmedizin Berlin, Berlin, Germany
Correspondence: Professor Reinhold Kreutz ([email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
August 22 2007
Revision Received:
October 03 2007
Accepted:
October 22 2007
Accepted Manuscript online:
October 22 2007
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2008 Biochemical Society
2008
Clin Sci (Lond) (2008) 114 (4): 305–311.
Article history
Received:
August 22 2007
Revision Received:
October 03 2007
Accepted:
October 22 2007
Accepted Manuscript online:
October 22 2007
Citation
Angela Schulz, Maria Schlesener, Judith Weiss, Jonna Hänsch, Norbert Wendt, Peter Kossmehl, Daniela Grimm, Roland Vetter, Reinhold Kreutz; Protective effect of female gender on the development of albuminuria in a polygenetic rat model is enhanced further by replacement of a major autosomal QTL. Clin Sci (Lond) 1 February 2008; 114 (4): 305–311. doi: https://doi.org/10.1042/CS20070300
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |